No spam - just the good stuff

Subscribe to our newsletter

News

Agetech

Large study finds brain training can reduce falls in older adults

£4m Longitude Prize on Dementia bags 175 entries

Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech

Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.

Longitude Prize on dementia names expert judging panel

Five key steps to getting an AgeTech startup funded

Aging in place is the “holy grail” of AgeTech

International Women’s Day: the wonderful women of longevity

Rosita Longevity over 60s health app launches in US

“World’s first” cultural-matching app for care sector launches

Wearable for seniors that tracks even subtle changes in activity launches

Aging in place trailblazer focus – UnaliWear

Aging in place trailblazer focus – Sentai

Fall detection powered by touchless tech and Amazon Alexa

Aging in place trailblazer focus – SensorsCall

Aging in place trailblazer focus – Savonix

Aging in place trailblazer focus – EchoCare

Aging in place trailblazer focus – GetSetUp

Aging in place trailblazer focus – Carewell

Aging in place: technologies to live long and independently

The three pillars for success in aging in place

Honor acquires Home Instead – big news for aging in place

Student designs smart mobility aid for dementia sufferers

Senior living tech is now a must-have

Huma’s $130m raise will scale its digital health platform

New investor offers funding to healthy aging innovators

Connected care start-up targets aging-in-place

AgeTech fund: focus on over-50s not millennials

Fall detection tech a focus for investors

At-home diagnostic system sees growth in older users

Stimulate your brain and boost your longevity

2021 hits the longevity ground running

AI fast-tracks human longevity extension

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.